Caplan syndrome: A Patient Guide
At a Glance
Caplan syndrome is the combination of rheumatoid arthritis and prior mineral dust exposure that can produce inflammatory lung nodules. Diagnosis requires careful evaluation to rule out infection or cancer, while care focuses on arthritis control and lung monitoring.
Caplan syndrome, also known as rheumatoid pneumoconiosis, is a rare medical condition that occurs when two separate health issues intersect: rheumatoid arthritis and a lung disease caused by inhaling mineral dust [1][2]. Because these nodules can appear quite suddenly and look strikingly similar to other serious conditions on an X-ray or CT scan, receiving this diagnosis always begins with a period of intense investigation to ensure that what appears to be an inflammatory reaction is not actually an infection, cancer, or another lung disease [3][4].
The biology of Caplan syndrome is complex and incompletely understood, but a proposed mechanism involves a delayed immune response. Even if you left a dusty work environment decades ago, mineral particles can remain trapped deep within your lung tissue. When rheumatoid arthritis—an autoimmune condition that causes joint inflammation—becomes active, it is believed that the immune system may interact with that old dust, surrounding it with inflammatory tissue to form a nodule [5][6]. This means the condition is often characterized by both the joint symptoms of arthritis, such as morning stiffness and swelling, and the presence of these lung nodules, which may or may not cause respiratory symptoms like a cough or shortness of breath [7][8].
Living with Caplan syndrome requires a collaborative approach to healthcare, as it bridges the expertise of both rheumatologists and pulmonologists. There is no single Caplan-specific treatment or monitoring protocol. Instead, management focuses on controlling the systemic inflammation of the underlying arthritis with specialized medications, while closely monitoring the lungs through planned, clinician-directed surveillance [9][10]. Stable imaging does not remove the need to report new symptoms. If nodules are new, enlarging, or cavitating, they require individualized reassessment to rule out infection or malignancy before any medication changes are made. By addressing the immune system’s activity, avoiding further environmental triggers, and adhering to your surveillance plan, you and your care team can work together to protect your lung health [4][11].
In this guide
6 chapters
Understanding Caplan Syndrome: When Your History Meets Your Health
Learn what Caplan syndrome means, why lung nodules can appear years after dust exposure, and how doctors distinguish inflammation from cancer, infection, or both.
Recognizing Symptoms and Warning Signs of Caplan Syndrome
Learn the symptoms and warning signs of Caplan syndrome, including joint pain, cough, breathlessness, emergency signs, and when to contact your care team.
The Biological Puzzle: Why Your Body Reacts to Old Dust
Learn how old silica or coal dust may contribute to Caplan syndrome, why its lung nodules mimic cancer or infection, and when biopsy or CT monitoring are used.
Imaging and Pathology: Making Sense of Your Reports
Learn how Caplan syndrome appears on CT and PET scans, what biopsy findings mean, and why infection or cancer may need to be carefully ruled out by your team.
Managing Your Health: Treatment and the Care Team Approach
Learn how Caplan syndrome is managed with rheumatoid arthritis treatment, lung monitoring, dust avoidance, infection prevention, and coordinated specialist care.
Living Well with Caplan Syndrome: Long-Term Monitoring and Care
Learn how Caplan syndrome is monitored long term with lung function tests, CT scans, infection prevention, symptom changes, and pulmonary rehabilitation.
Common questions in this guide
What is Caplan syndrome?
What symptoms can Caplan syndrome cause?
How is Caplan syndrome diagnosed?
How is Caplan syndrome treated and monitored?
Why do changing lung nodules need to be checked again?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Caplan syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my history and imaging, what is the current assessment of how my joints and lungs are interacting?
- 2.Who will be the primary point of contact for coordinating communication between my rheumatologist and pulmonologist?
- 3.What specific imaging or symptoms should we be tracking most closely to ensure we aren't missing an infection or other complication?
- 4.How does my past work history influence the individualized surveillance plan we will use for my lung health moving forward?
References
References (11)
- 1
Amyloid A amyloidosis in a patient with Caplan's syndrome, with special reference to genetic predisposition.
Nakamura T, Shiraishi N, Morikami Y, et al.
Modern rheumatology case reports 2020; (4(2)):212-217 doi:10.1080/24725625.2020.1749361.
PMID: 33087017 - 2
Caplan's Syndrome with a twist.
Deepak J, Kenaa B
International journal of clinical case reports and reviews : open access 2020; (2(1)) doi:10.31579/2690-4861/007.
PMID: 34027516 - 3
Caplan syndrome in the 21st century: Cavitary nodules and delayed rheumatoid arthritis.
Hasanli YS
Occupational medicine (Oxford, England) 2025; (75(8)):535-539 doi:10.1093/occmed/kqaf094.
PMID: 40907968 - 4
A four-year follow-up of Caplan's syndrome: A case report.
Wang L, Liu Y, Zhang Y, Hu Y
The Journal of international medical research 2025; (53(6)):3000605251353738 doi:10.1177/03000605251353738.
PMID: 40586547 - 5
Erasmus Syndrome: Association of Silicosis and Systemic Sclerosis.
Sharma RK, Sharma AK, Sharma A
Indian dermatology online journal 2018; (9(3)):185-187 doi:10.4103/idoj.IDOJ_201_17.
PMID: 29854640 - 6
Silica-mediated exacerbation of inflammatory arthritis: A novel murine model.
Janssen LMF, de Ocampo C, Kono DH, et al.
bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.01.07.631488.
PMID: 39829788 - 7
Case Report: The entanglement of infection and autoimmunity: a case of Caplan syndrome.
Xiong Z, Wu Y, Tan J, et al.
Frontiers in immunology 2026; (17()):1715034 doi:10.3389/fimmu.2026.1715034.
PMID: 41822473 - 8
Caplan Syndrome: A Case Report.
Laouali AMM, Soumaila M, Tinni IA, et al.
Clinical case reports 2026; (14(1)):e71864 doi:10.1002/ccr3.71864.
PMID: 41541043 - 9
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Smolen JS, Landewé RBM, Bergstra SA, et al.
Annals of the rheumatic diseases 2023; (82(1)):3-18 doi:10.1136/ard-2022-223356.
PMID: 36357155 - 10
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Johnson SR, Bernstein EJ, Bolster MB, et al.
Arthritis care & research 2024; (76(8)):1070-1082 doi:10.1002/acr.25347.
PMID: 38973729 - 11
Treatment of rheumatoid arthritis-associated interstitial lung disease: An appraisal of the 2023 ACR/CHEST guideline.
Saavedra AA, Mueller KT, Kowalski EN, et al.
Current treatment options in rheumatology 2024; (10(4)):43-60 doi:10.1007/s40674-024-00217-3.
PMID: 39822854
This page is for informational purposes only and does not constitute medical advice about Caplan syndrome. Your rheumatologist and pulmonologist can interpret your symptoms and imaging and tailor monitoring or treatment to your situation.